What is Type 2 Diabetes?
Type 2 Diabetes is a chronic metabolic disorder
characterized by persistent high blood glucose (hyperglycemia) resulting
from:
- Insulin
resistance – the body's cells do not respond effectively to insulin.
- Progressive
pancreatic β-cell dysfunction – the pancreas gradually loses its
ability to produce sufficient insulin.
Unlike Type 1 Diabetes, where insulin production is severely
reduced due to autoimmune destruction of β-cells, patients with Type 2 Diabetes
usually continue to produce insulin, especially in the early stages, but it is
insufficient to overcome insulin resistance.
Normal Glucose Metabolism
Under normal conditions:
- Food
is digested into glucose.
- Blood
glucose rises.
- The
pancreas releases insulin.
- Insulin
binds to receptors on muscle, liver, and fat cells.
- Glucose
enters cells and is used for energy or stored as glycogen.
- Blood
glucose returns to normal.
What Happens in Type 2 Diabetes?
1. Insulin Resistance
The body's cells become less responsive to insulin.
As a result:
- Less
glucose enters muscle and fat cells.
- The
liver continues producing glucose even when it is not needed.
- Blood
glucose remains elevated.
Initially, the pancreas compensates by producing more
insulin (hyperinsulinemia).
2. Progressive β-cell Dysfunction
Over time:
- Pancreatic
β-cells become exhausted.
- Insulin
secretion declines.
- Blood
glucose levels continue to rise.
Eventually, many patients require insulin therapy because
endogenous insulin production becomes inadequate.
Major Causes of Type 2 Diabetes
Type 2 Diabetes develops due to a combination of genetic
susceptibility and environmental/lifestyle factors.
1. Genetics
- Family
history significantly increases risk.
- Multiple
genes influence insulin secretion and insulin sensitivity.
- Risk
is higher if one or both parents have diabetes.
2. Obesity (Most Important Modifiable Risk Factor)
Excess body fat, particularly visceral (abdominal) fat,
promotes insulin resistance.
Fat tissue releases:
- Free
fatty acids
- Pro-inflammatory
cytokines
- Adipokines
These interfere with insulin signaling.
3. Physical Inactivity
Lack of exercise leads to:
- Reduced
glucose uptake by muscles
- Increased
insulin resistance
- Weight
gain
Regular physical activity improves insulin sensitivity.
4. Unhealthy Diet
High intake of:
- Refined
carbohydrates
- Sugary
beverages
- Processed
foods
- Saturated
and trans fats
contributes to:
- Weight
gain
- Chronic
inflammation
- Insulin
resistance
5. Aging
Risk increases after 45 years, although Type 2
Diabetes is becoming increasingly common in younger adults and adolescents due
to rising obesity rates.
6. Metabolic Syndrome
People with:
- Central
obesity
- High
blood pressure
- Elevated
triglycerides
- Low
HDL cholesterol
- Insulin
resistance
have a markedly increased risk of developing Type 2
Diabetes.
7. Hormonal Disorders
Certain conditions increase insulin resistance, including:
- Polycystic
Ovary Syndrome
- Cushing
syndrome
- Acromegaly
8. Certain Medications
Long-term use of some drugs may increase diabetes risk, such
as:
- Corticosteroids
- Some
antipsychotics
- Certain
immunosuppressants
9. Smoking
Smoking:
- Increases
systemic inflammation
- Promotes
insulin resistance
- Raises
the risk of cardiovascular complications
10. Chronic Stress and Poor Sleep
These factors increase stress hormones (e.g., cortisol),
which:
- Increase
blood glucose
- Worsen
insulin resistance
- Promote
weight gain
Common Symptoms
- Increased
thirst (polydipsia)
- Frequent
urination (polyuria)
- Increased
hunger (polyphagia)
- Fatigue
- Blurred
vision
- Slow
wound healing
- Recurrent
infections
- Unexplained
weight loss (in advanced disease)
- Numbness
or tingling in the hands and feet
Complications (If Untreated)
Microvascular complications
- Diabetic
retinopathy
- Diabetic
nephropathy
- Diabetic
neuropathy
Macrovascular complications
- Coronary
artery disease
- Stroke
- Peripheral
artery disease
Key Takeaway
Type 2 Diabetes is a progressive metabolic disease caused by
the combined effects of insulin resistance and declining pancreatic
β-cell function. While genetics influence susceptibility, major modifiable
contributors include obesity, physical inactivity, unhealthy diet, smoking, and
chronic stress. Early diagnosis and lifestyle changes, along with appropriate
medication when needed, can help control blood glucose and reduce the risk of
long-term complications.
Line of Treatment for Type 2 Diabetes Mellitus (T2DM)
with Mechanism of Action
The treatment of Type 2 Diabetes follows a stepwise approach
aimed at:
- Achieving
glycemic control (HbA1c target usually <7%, individualized)
- Preventing
microvascular and macrovascular complications
- Reducing
cardiovascular and renal risk
- Preserving
pancreatic β-cell function
Step 1: Lifestyle Modification (First-Line Therapy)
Mechanism of Action
Medical Nutrition Therapy
- Reduces
postprandial glucose excursions
- Decreases
calorie intake and body weight
- Improves
insulin sensitivity
- Reduces
hepatic glucose production
Regular Physical Activity
- Increases
GLUT-4 transporter translocation in skeletal muscle
- Enhances
glucose uptake independent of insulin
- Improves
insulin sensitivity
- Reduces
visceral fat
Weight Reduction
- Decreases
inflammatory cytokines
- Improves
insulin receptor signaling
- Lowers
insulin resistance
- Preserves
β-cell function
Step 2: Pharmacological Therapy
1. Metformin (First-Line Drug)
Examples
- Metformin
Mechanism of Action
✔ Activates AMP-activated
protein kinase (AMPK)
Effects:
- ↓
Hepatic gluconeogenesis
- ↓
Intestinal glucose absorption
- ↑
Peripheral insulin sensitivity
- ↑
Muscle glucose uptake
- Mild
weight loss
- No
hypoglycemia when used alone
Clinical Benefits
- First-line
therapy worldwide
- HbA1c
reduction: 1–1.5%
- Weight
neutral or modest weight loss
- Cardiovascular
benefit
- Low
cost
2. SGLT2 Inhibitors
Examples
- Empagliflozin
- Dapagliflozin
- Canagliflozin
Mechanism of Action
Acts in the proximal renal tubule by:
- Blocking
Sodium-Glucose Co-transporter-2 (SGLT2)
- Preventing
glucose reabsorption
- Increasing
urinary glucose excretion
- Lowering
blood glucose independently of insulin
Additional Benefits
- Weight
loss
- Blood
pressure reduction
- Cardiovascular
protection
- Renal
protection
- Reduced
hospitalization for heart failure
3. GLP-1 Receptor Agonists
Examples
- Semaglutide
- Liraglutide
- Dulaglutide
Mechanism of Action
Mimic endogenous GLP-1 hormone:
- Increase
glucose-dependent insulin secretion
- Decrease
glucagon secretion
- Delay
gastric emptying
- Increase
satiety
- Reduce
appetite
Additional Benefits
- Significant
weight loss
- Low
hypoglycemia risk
- Cardiovascular
protection
- Improvement
in fatty liver disease
4. DPP-4 Inhibitors
Examples
- Sitagliptin
- Linagliptin
- Vildagliptin
Mechanism of Action
- Inhibit
DPP-4 enzyme
- Prevent
degradation of endogenous GLP-1 and GIP
- Increase
insulin secretion
- Decrease
glucagon release
Benefits
- Weight
neutral
- Low
risk of hypoglycemia
- Well
tolerated
5. Sulfonylureas
Examples
- Glimepiride
- Gliclazide
Mechanism of Action
- Close
ATP-sensitive potassium channels on pancreatic β-cells
- Depolarize
β-cell membrane
- Open
calcium channels
- Trigger
insulin release
Advantages
- Rapid
glucose lowering
- Inexpensive
Limitations
- Hypoglycemia
- Weight
gain
6. Thiazolidinediones (TZDs)
Examples
- Pioglitazone
Mechanism of Action
Activates PPAR-γ receptors leading to:
- Improved
insulin sensitivity
- Increased
glucose uptake
- Reduced
hepatic glucose production
- Redistribution
of fat away from visceral depots
Benefits
- Improves
insulin resistance
- Durable
HbA1c reduction
Limitations
- Weight
gain
- Fluid
retention
- Risk
of heart failure in susceptible patients
7. Alpha-Glucosidase Inhibitors
Examples
- Acarbose
Mechanism of Action
- Inhibit
intestinal alpha-glucosidase enzymes
- Delay
carbohydrate digestion
- Reduce
postprandial glucose spikes
8. Meglitinides
Examples
- Repaglinide
Mechanism of Action
- Stimulate
rapid insulin secretion
- Particularly
effective for post-meal glucose control
9. Insulin Therapy
Indicated when:
- HbA1c
remains uncontrolled despite oral agents
- Severe
hyperglycemia
- Symptomatic
diabetes
- Acute
illness, surgery, or pregnancy
Mechanism of Action
Exogenous insulin:
- Promotes
glucose uptake by muscle and adipose tissue
- Suppresses
hepatic glucose production
- Inhibits
lipolysis
- Promotes
glycogen synthesis
- Reduces
blood glucose
Recommended Treatment Sequence (ADA/EASD-Based)
|
Stage |
Preferred Treatment |
|
Newly diagnosed |
Lifestyle modification + Metformin |
|
HbA1c above target |
Add SGLT2 inhibitor or GLP-1 receptor agonist (especially
if cardiovascular disease, heart failure, chronic kidney disease, or obesity
are present) |
|
Further uncontrolled |
Triple therapy with complementary drug classes |
|
Persistent uncontrolled or symptomatic hyperglycemia |
Initiate basal insulin ± GLP-1 receptor agonist |
|
Advanced disease |
Basal-bolus insulin regimen if needed |
Summary of Drug Classes and Mechanisms
|
Drug Class |
Primary Mechanism |
Major Benefit |
|
Metformin |
↓ Hepatic glucose production; ↑ insulin sensitivity |
First-line, weight neutral |
|
SGLT2 inhibitors |
↑ Urinary glucose excretion |
Cardio-renal protection, weight loss |
|
GLP-1 receptor agonists |
↑ Insulin, ↓ glucagon, delayed gastric emptying |
Weight loss, cardiovascular benefit |
|
DPP-4 inhibitors |
↑ Endogenous incretin activity |
Weight neutral, low hypoglycemia risk |
|
Sulfonylureas |
↑ Pancreatic insulin secretion |
Potent glucose lowering, low cost |
|
TZDs |
↑ Peripheral insulin sensitivity |
Improves insulin resistance |
|
Alpha-glucosidase inhibitors |
Delays carbohydrate absorption |
Reduces postprandial glucose |
|
Meglitinides |
Rapid insulin secretion |
Controls post-meal glucose |
|
Insulin |
Replaces endogenous insulin |
Most effective for lowering glucose |
Below are some of the major anti-diabetic brands commonly
prescribed in India along with their manufacturers. (Availability may vary
by region and many companies also market generic versions.)
|
Molecule |
Major Brand |
Manufacturer |
|
Metformin |
Glycomet |
USV Pvt. Ltd. |
|
Cetapin |
Sanofi India |
|
|
Obimet |
Corona Remedies |
|
|
Metlong |
Sun Pharmaceutical Industries |
|
|
Glimepiride |
Amaryl |
Sanofi India |
|
Glimisave |
Eris Lifesciences |
|
|
Glimy |
Micro Labs |
|
|
Gliclazide |
Diamicron MR |
Servier India |
|
Teneligliptin |
Zita |
Glenmark Pharmaceuticals |
|
Teneza |
Sun Pharmaceutical Industries |
|
|
Tenglyn |
Mankind Pharma |
|
|
Sitagliptin |
Januvia |
Merck Sharp & Dohme (MSD) |
|
Istavel |
Sun Pharmaceutical Industries |
|
|
Vildagliptin |
Galvus |
Novartis India |
|
Jalra |
USV Pvt. Ltd. |
|
|
Linagliptin |
Trajenta |
Boehringer Ingelheim |
|
Linamac |
Macleods Pharmaceuticals |
|
|
Empagliflozin |
Jardiance |
Boehringer Ingelheim |
|
Dapagliflozin |
Forxiga |
AstraZeneca |
|
Oxra |
Sun Pharmaceutical Industries |
|
|
Dapasmart |
Mankind Pharma |
|
|
Canagliflozin |
Invokana* |
Johnson & Johnson (Janssen) |
|
Pioglitazone |
Pioz |
USV Pvt. Ltd. |
|
Glizone |
Eris Lifesciences |
|
|
Acarbose |
Glucobay |
Bayer |
|
Voglibose |
Volix |
Sun Pharmaceutical Industries |
|
Voglimac |
Macleods Pharmaceuticals |
Common Fixed-Dose Combination (FDC) Brands in India
|
Combination |
Popular Brand |
Manufacturer |
|
Metformin + Glimepiride |
Amaryl M |
Sanofi India |
|
Metformin + Glimepiride |
Glimisave M |
Eris Lifesciences |
|
Metformin + Teneligliptin |
Zita-Met |
Glenmark Pharmaceuticals |
|
Metformin + Sitagliptin |
Janumet |
Merck Sharp & Dohme (MSD) |
|
Metformin + Vildagliptin |
Galvus Met |
Novartis India |
|
Metformin + Linagliptin |
Trajenta Duo |
Boehringer Ingelheim |
|
Metformin + Empagliflozin |
Jardiance Duo / Synjardy |
Boehringer Ingelheim |
|
Metformin + Dapagliflozin |
Xigduo XR |
AstraZeneca |
|
Metformin + Pioglitazone |
Pioz MF |
USV Pvt. Ltd. |
|
Metformin + Voglibose |
Volix M |
Sun Pharmaceutical Industries |
Top Companies in the Indian Anti-Diabetic Market
Some of the leading manufacturers in India's diabetes
segment include:
- Sun
Pharmaceutical Industries
- USV
Pvt. Ltd.
- Sanofi
India
- Eris
Lifesciences
- Glenmark
Pharmaceuticals
- Mankind
Pharma
- Micro
Labs
- Macleods
Pharmaceuticals
- Boehringer
Ingelheim
- AstraZeneca
- Merck
Sharp & Dohme (MSD)
- Novartis
India
- Bayer
Note: Brand portfolios and marketing rights may
change over time, and some multinational brands may also be marketed through
local licensing arrangements in India.
Precautions and Lifestyle Changes for Type 2 Diabetes
Mellitus (T2DM)
Lifestyle modification is the cornerstone of Type 2
Diabetes management. Along with medications, adopting healthy habits helps
improve glycemic control, reduce complications, and enhance quality of life.
Precautions
1. Monitor Blood Glucose Regularly
- Check
fasting and postprandial blood glucose as advised.
- Monitor
HbA1c every 3–6 months.
- Maintain
a record of blood glucose readings.
Target Values (general)
- Fasting:
80–130 mg/dL
- 2-hour
post-meal: <180 mg/dL
- HbA1c:
<7% (individualized based on age and comorbidities)
2. Take Medications as Prescribed
- Do
not skip doses.
- Take
medicines at the recommended time.
- Never
stop medication without consulting your physician.
3. Recognize Hypoglycemia (Low Blood Sugar)
Symptoms
- Sweating
- Trembling
- Hunger
- Palpitations
- Dizziness
- Confusion
- Blurred
vision
Immediate Management
- Consume
15–20 g of fast-acting carbohydrate (e.g., glucose tablets, glucose
powder dissolved in water, or fruit juice).
- Recheck
blood glucose after 15 minutes and repeat if necessary.
4. Prevent Hyperglycemia
Seek medical advice if blood glucose remains persistently
high or if you experience:
- Excessive
thirst
- Frequent
urination
- Fatigue
- Blurred
vision
- Unexplained
weight loss
5. Foot Care
People with diabetes are at increased risk of nerve damage
and poor wound healing.
Recommendations
- Inspect
feet daily.
- Wash
and dry feet thoroughly, especially between the toes.
- Wear
comfortable, well-fitting footwear.
- Avoid
walking barefoot.
- Seek
prompt medical attention for cuts, blisters, or ulcers.
6. Eye Care
- Have
a comprehensive dilated eye examination every year to screen for
diabetic retinopathy.
- Report
any sudden changes in vision promptly.
7. Kidney Care
- Monitor
kidney function and urine albumin as recommended.
- Keep
blood pressure under control.
- Stay
adequately hydrated.
8. Blood Pressure and Cholesterol Control
Maintaining healthy blood pressure and lipid levels reduces
the risk of cardiovascular disease.
Typical targets (individualized):
- Blood
pressure: <130/80 mmHg (for many patients)
- LDL
cholesterol: Based on overall cardiovascular risk and physician
recommendations
9. Avoid Smoking and Limit Alcohol
- Quit
smoking to reduce cardiovascular and vascular complications.
- Limit
alcohol intake and avoid drinking on an empty stomach, as it may increase
the risk of hypoglycemia (particularly in people using insulin or insulin
secretagogues).
Lifestyle Changes
1. Healthy Diet
Include
- Whole
grains
- Green
leafy vegetables
- High-fiber
foods
- Legumes
and pulses
- Low-fat
dairy products
- Lean
protein (fish, skinless poultry, soy, eggs)
- Nuts
and seeds (in moderation)
- Healthy
fats (olive oil, mustard oil, groundnut oil)
Limit
- Sugary
beverages
- Sweets
and desserts
- Refined
flour products
- White
bread and white rice (large portions)
- Processed
and fast foods
- Deep-fried
foods
- Excess
saturated and trans fats
2. Portion Control
- Eat
smaller, balanced meals.
- Avoid
overeating.
- Maintain
regular meal timings.
- Avoid
prolonged fasting followed by heavy meals.
3. Regular Physical Activity
Aim for:
- At
least 150 minutes/week of moderate-intensity aerobic exercise (e.g.,
brisk walking, cycling, swimming)
- Resistance
(strength) training 2–3 days/week
- Flexibility
and balance exercises, particularly in older adults
Physical activity:
- Improves
insulin sensitivity
- Helps
lower blood glucose
- Supports
weight management
- Reduces
cardiovascular risk
4. Weight Management
- Even
5–10% weight loss can significantly improve insulin sensitivity and
glycemic control in overweight or obese individuals.
5. Adequate Sleep
- Aim
for 7–9 hours of quality sleep per night.
- Poor
sleep can worsen insulin resistance and glucose control.
6. Stress Management
Chronic stress can increase blood glucose through stress
hormones.
Helpful strategies include:
- Meditation
- Yoga
- Deep
breathing exercises
- Mindfulness
- Relaxation
techniques
- Engaging
in enjoyable hobbies
7. Stay Hydrated
- Drink
sufficient water throughout the day.
- Avoid
sugar-sweetened beverages.
8. Routine Health Check-ups
Regularly monitor:
- HbA1c
- Blood
pressure
- Lipid
profile
- Kidney
function
- Eye
health
- Foot
health
- Dental
health
Foods to Prefer vs. Foods to Limit
|
Prefer |
Limit/Avoid |
|
Whole grains |
Sugary drinks |
|
Green leafy vegetables |
Sweets and candies |
|
Fresh fruits (controlled portions) |
Cakes, pastries, desserts |
|
Legumes and pulses |
Refined flour products |
|
Lean protein |
Deep-fried foods |
|
High-fiber foods |
Processed snacks |
|
Nuts (moderation) |
Trans fats |
|
Healthy oils |
Excess alcohol |
Daily Lifestyle Checklist
✅ Take medications as prescribed
✅
Monitor blood glucose regularly
✅
Eat balanced, portion-controlled meals
✅
Exercise for at least 30 minutes on most days
✅
Stay hydrated
✅
Get adequate sleep (7–9 hours)
✅
Avoid smoking and limit alcohol
✅
Check your feet daily
✅
Attend regular medical follow-ups
✅
Manage stress effectively
Commonly Used Nutritional Supplements in Type 2 Diabetes
Mellitus (T2DM)
Nutritional supplements are adjuncts to lifestyle
modification and standard antidiabetic medications. They are not substitutes
for prescribed glucose-lowering therapy, but selected supplements may
support glycemic control, insulin sensitivity, antioxidant status, or
management of diabetes-related complications when used appropriately.
|
Supplement |
Role in Diabetes |
Common Indian Brands* |
Manufacturer |
|
Alpha-Lipoic Acid |
Antioxidant; supports diabetic neuropathy |
Nervup OD, A to Z NS+ |
Mankind Pharma, Alkem Laboratories |
|
Benfotiamine |
Helps prevent and manage diabetic neuropathy |
Benfomet Plus, Benalgis |
Sun Pharmaceutical Industries, Intas Pharmaceuticals |
|
Methylcobalamin |
Supports nerve repair and treats B12 deficiency (common
with long-term metformin use) |
Nurokind, Mecobal |
Mankind Pharma, P & G Health |
|
Vitamin D3 |
Corrects deficiency; may support insulin sensitivity |
Uprise-D3, D-Rise |
Alkem Laboratories, USV Pvt. Ltd. |
|
Magnesium |
Supports insulin action in deficient individuals |
Magvit, Magnical |
Various manufacturers |
|
Chromium Picolinate |
May improve insulin sensitivity in selected patients |
Chrominac, Chromium Picolinate capsules |
Various nutraceutical companies |
|
Omega-3 Fatty Acids |
Supports cardiovascular health and triglyceride reduction |
Maxepa, Omacor |
Abbott, Abbott Healthcare |
|
Coenzyme Q10 |
Antioxidant; supports cardiovascular and mitochondrial
function |
CoQ Forte, Q-Gel |
Various manufacturers |
|
Myo-Inositol |
May improve insulin sensitivity in selected patients |
Multiple nutraceutical brands |
Various manufacturers |
|
Probiotics |
Supports gut microbiota; potential metabolic benefits |
Vizylac, Darolac |
USV Pvt. Ltd., Aristo Pharmaceuticals |
Diabetes-Specific Nutritional Formulas
These meal replacements or diabetes nutrition formulas are
commonly recommended for people with diabetes.
|
Brand |
Manufacturer |
Key Features |
|
Ensure Diabetes Care |
Abbott |
High protein, low glycemic index, fiber-enriched |
|
Prohance-D |
Sun Pharmaceutical Industries |
Protein-rich diabetes nutrition |
|
Resource Diabetic |
Nestlé Health Science |
Low-GI formula with balanced nutrients |
|
Diasip |
Danone Nutricia |
Low glycemic index, fiber-enriched |
Ingredients Commonly Used in Diabetes Nutraceuticals
Many Indian nutraceutical products for diabetes contain one
or more of the following:
- Berberine
- Cinnamon
Extract
- Fenugreek
Extract
- Gymnema
sylvestre
- Bitter
Melon Extract
- Curcumin
- Alpha-Lipoic
Acid
- Chromium
Picolinate
- Magnesium
- Vitamin
D3
- Methylcobalamin
Most Frequently Recommended Supplements by Clinical
Scenario
|
Clinical Situation |
Common Supplement(s) |
|
Long-term metformin therapy |
Methylcobalamin (Vitamin B12) |
|
Diabetic neuropathy |
Alpha-lipoic acid + Benfotiamine + Methylcobalamin |
|
Vitamin D deficiency |
Vitamin D3 |
|
Hypertriglyceridemia |
Omega-3 fatty acids |
|
Antioxidant support |
Coenzyme Q10, Alpha-lipoic acid |
|
Insulin resistance (selected patients) |
Chromium picolinate, Magnesium (if deficient),
Myo-inositol |
DISCLAIMER - All details provided regarding diseases
and medicines have been collated from sources in the public domain and are for
general awareness purposes only. This information does not constitute medical
advice. It is strongly advised not to depend on online information and to
always consult a qualified Medical Doctor for a better understanding of any
disease, its symptoms, and its treatment. DO NOT SELF MEDICATE under any
circumstances. Medicines should only be consumed as prescribed by a registered
medical practitioner; a valid prescription may be required for scheduled drugs
as per applicable Indian law. GENHEALTH shall not be held responsible for any
action taken based on the information provided on this platform. In case of a
medical emergency, please contact your nearest hospital or dial emergency
services immediately.